help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Orio, F.
Right arrow Articles by Colao, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orio, F., Jr.
Right arrow Articles by Colao, A.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 9 4588-4593
Copyright © 2004 by The Endocrine Society

Early Impairment of Endothelial Structure and Function in Young Normal-Weight Women with Polycystic Ovary Syndrome

Francesco Orio, Jr., Stefano Palomba, Teresa Cascella, Biagio De Simone, Sebastiano Di Biase, Tiziana Russo, Donato Labella, Fulvio Zullo, Gaetano Lombardi and Annamaria Colao

Department of Molecular & Clinical Endocrinology and Oncology (F.O., T.C., G.L., A.C.) and Institute of Internal Medicine and Metabolic Disease (B.D.S.), University "Federico II", 80131 Naples, Italy; Department of Obstetrics and Gynecology (S.P., T.R., F.Z.), University of Catanzaro "Magna Graecia", 88100 Catanzaro, Italy; and "MeriGen" Laboratory of Molecular Biology (S.D.B., D.L.), 80131 Naples, Italy

Address all correspondence and requests for reprints to: Francesco Orio, M.D., Department of Molecular & Clinical Endocrinology and Oncology, University "Federico II" of Naples, Via S. Pansini 5, 80131 Naples, Italy. E-mail: francescoorio{at}virgilio.it.

The aim of this study was to evaluate the presence of early vascular damage in young normal-weight women with polycystic ovary syndrome (PCOS).

Thirty young normal-weight women with PCOS, who had no additional metabolic or cardiovascular diseases, and 30 healthy women (controls) matched for age and body mass index were studied. A complete hormonal assay was performed in each subject. Serum insulin and glucose levels were measured at baseline and after the oral glucose tolerance test. Plasma endothelin-1 levels and serum lipid profile were also assessed. The endothelial function was studied by flow-mediated dilation on the brachial artery, and arterial structure was evaluated by intima-media thickness measurement using Doppler ultrasound of both common carotid arteries.

A significant (P < 0.05) difference in flow-mediated dilation (14.3 ± 1.9% vs. 18.1 ± 2.0% for PCOS patients and controls, respectively) and in intima-media thickness (0.53 ± 0.09 mm vs. 0.39 ± 0.08 mm for PCOS patients and controls, respectively) was found between PCOS and control subjects. Serum endothelin-1 levels were also significantly (P < 0.05) higher in PCOS patients compared with controls (1.1 ± 0.4 pmol/liter vs. 0.5 ± 0.2 pmol/liter for PCOS patients and controls, respectively).

In conclusion, our data show that young, normal-weight, nondyslipidemic, nonhypertensive women with PCOS have an early impairment of endothelial structure and function.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
M. Jensterle, M. Sebestjen, A. Janez, J. Prezelj, T. Kocjan, I. Keber, and M. Pfeifer
Improvement of endothelial function with metformin and rosiglitazone treatment in women with polycystic ovary syndrome
Eur. J. Endocrinol., October 1, 2008; 159(4): 399 - 406.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
D. Romualdi, B. Costantini, L. Selvaggi, M. Giuliani, F. Cristello, F. Macri, A. Bompiani, A. Lanzone, and M. Guido
Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective
Hum. Reprod., September 1, 2008; 23(9): 2127 - 2133.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E. Diamanti-Kandarakis, S. Livadas, S. A Kandarakis, A. Margeli, and I. Papassotiriou
Serum concentrations of atherogenic proteins neutrophil gelatinase-associated lipocalin and its complex with matrix metalloproteinase-9 are significantly lower in women with polycystic ovary syndrome: hint of a protective mechanism?
Eur. J. Endocrinol., April 1, 2008; 158(4): 525 - 531.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. E. Nestler
Metformin for the Treatment of the Polycystic Ovary Syndrome
N. Engl. J. Med., January 3, 2008; 358(1): 47 - 54.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Heutling, H. Schulz, I. Nickel, J. Kleinstein, P. Kaltwasser, S. Westphal, F. Mittermayer, M. Wolzt, K. Krzyzanowska, H. Randeva, et al.
Asymmetrical Dimethylarginine, Inflammatory and Metabolic Parameters in Women with Polycystic Ovary Syndrome before and after Metformin Treatment
J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 82 - 90.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Cascella, S. Palomba, I. De Sio, F. Manguso, F. Giallauria, B. De Simone, D. Tafuri, G. Lombardi, A. Colao, and F. Orio
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome
Hum. Reprod., January 1, 2008; 23(1): 153 - 159.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Palomba, A. Falbo, T. Russo, F. Manguso, A. Tolino, F. Zullo, P. De Feo, and F. Orio Jr.
Insulin Sensitivity after Metformin Suspension in Normal-Weight Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 3128 - 3135.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Orio, F. Manguso, S. Di Biase, A. Falbo, F. Giallauria, D. Labella, A. Tolino, G. Lombardi, A. Colao, and S. Palomba
Metformin administration improves leukocyte count in women with polycystic ovary syndrome: a 6-month prospective study
Eur. J. Endocrinol., July 1, 2007; 157(1): 69 - 73.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Hu, A. Leonard, A. Seifalian, and P. Hardiman
Vascular dysfunction during pregnancy in women with polycystic ovary syndrome
Hum. Reprod., June 1, 2007; 22(6): 1532 - 1539.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
J. A. Beckman, A. B. Goldfine, A. Dunaif, M. Gerhard-Herman, and M. A. Creager
Endothelial Function Varies According to Insulin Resistance Disease Type
Diabetes Care, May 1, 2007; 30(5): 1226 - 1232.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Vigorito, F. Giallauria, S. Palomba, T. Cascella, F. Manguso, R. Lucci, A. De Lorenzo, D. Tafuri, G. Lombardi, A. Colao, et al.
Beneficial Effects of a Three-Month Structured Exercise Training Program on Cardiopulmonary Functional Capacity in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1379 - 1384.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. Meyer, B. P. McGrath, and H. J. Teede
Effects of Medical Therapy on Insulin Resistance and the Cardiovascular System in Polycystic Ovary Syndrome
Diabetes Care, March 1, 2007; 30(3): 471 - 478.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Ibanez, A. Jaramillo, G. Enriquez, E. Miro, A. Lopez-Bermejo, D. Dunger, and F. de Zegher
Polycystic ovaries after precocious pubarche: relation to prenatal growth
Hum. Reprod., February 1, 2007; 22(2): 395 - 400.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. Cascella, S. Palomba, L. Tauchmanova, F. Manguso, S. Di Biase, D. Labella, F. Giallauria, C. Vigorito, A. Colao, G. Lombardi, et al.
Serum Aldosterone Concentration and Cardiovascular Risk in Women with Polycystic Ovarian Syndrome
J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4395 - 4400.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
The ESHRE Capri Workshop Group
Hormones and cardiovascular health in women
Hum. Reprod. Update, September 1, 2006; 12(5): 483 - 497.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., F. Giallauria, S. Palomba, T. Cascella, F. Manguso, L. Vuolo, T. Russo, A. Tolino, G. Lombardi, A. Colao, et al.
Cardiopulmonary Impairment in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., August 1, 2006; 91(8): 2967 - 2971.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
D. Macut, S. Damjanovic, D. Panidis, N. Spanos, B. Glisic, M. Petakov, D. Rousso, A. Kourtis, J. Bjekic, and N. Milic
Oxidised low-density lipoprotein concentration - early marker of an altered lipid metabolism in young women with PCOS.
Eur. J. Endocrinol., July 1, 2006; 155(1): 131 - 136.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
A Dagre, J Lekakis, C Mihas, A Protogerou, L Thalassinou, D Tryfonopoulos, G Douridas, C Papamichael, and M Alevizaki
Association of dehydroepiandrosterone-sulfate with endothelial function in young women with polycystic ovary syndrome.
Eur. J. Endocrinol., June 1, 2006; 154(6): 883 - 890.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. Ibanez and F. de Zegher
Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women
Hum. Reprod. Update, May 1, 2006; 12(3): 243 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Paradisi, A. Biaggi, R. Savone, F. Ianniello, C. Tomei, L. Caforio, and A. Caruso
Cardiovascular Risk Factors in Healthy Women with Previous Gestational Hypertension
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1233 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Topcu, M. Caliskan, E. E. Ozcimen, D. Tok, A. Uckuyu, D. Erdogan, H. Gullu, A. Yildirir, H. Zeyneloglu, and H. Muderrisoglu
Do young women with polycystic ovary syndrome show early evidence of preclinical coronary artery disease?
Hum. Reprod., April 1, 2006; 21(4): 930 - 935.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
S. Palomba, T. Russo, F. Orio Jr, A. Falbo, F. Manguso, T. Cascella, A. Tolino, E. Carmina, A. Colao, and F. Zullo
Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome
Hum. Reprod., February 1, 2006; 21(2): 457 - 465.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. Orio Jr., S. Palomba, T. Cascella, B. De Simone, F. Manguso, S. Savastano, T. Russo, A. Tolino, F. Zullo, G. Lombardi, et al.
Improvement in Endothelial Structure and Function after Metformin Treatment in Young Normal-Weight Women with Polycystic Ovary Syndrome: Results of a 6-Month Study
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6072 - 6076.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Meyer, B. P. McGrath, and H. J. Teede
Overweight Women with Polycystic Ovary Syndrome Have Evidence of Subclinical Cardiovascular Disease
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5711 - 5716.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Kravariti, K. K. Naka, S. N. Kalantaridou, N. Kazakos, C. S. Katsouras, A. Makrigiannakis, E. A. Paraskevaidis, G. P. Chrousos, A. Tsatsoulis, and L. K. Michalis
Predictors of Endothelial Dysfunction in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 2005; 90(9): 5088 - 5095.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Vural, E. Caliskan, E. Turkoz, T. Kilic, and A. Demirci
Evaluation of metabolic syndrome frequency and premature carotid atherosclerosis in young women with polycystic ovary syndrome
Hum. Reprod., September 1, 2005; 20(9): 2409 - 2413.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
E Diamanti-Kandarakis, K Alexandraki, A Protogerou, C Piperi, C Papamichael, A Aessopos, J Lekakis, and M Mavrikakis
Metformin administration improves endothelial function in women with polycystic ovary syndrome
Eur. J. Endocrinol., May 1, 2005; 152(5): 749 - 756.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Vryonidou, A. Papatheodorou, A. Tavridou, T. Terzi, V. Loi, I.-A. Vatalas, N. Batakis, C. Phenekos, and A. Dionyssiou-Asteriou
Association of Hyperandrogenemic and Metabolic Phenotype with Carotid Intima-Media Thickness in Young Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2740 - 2746.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. A. Ehrmann
Polycystic Ovary Syndrome
N. Engl. J. Med., March 24, 2005; 352(12): 1223 - 1236.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society